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Quantification of transcription <p>An analysis is described, applicable to any spotted microarray dataset that is produced using genomic DNA as a reference for quanti- fying prokaryotic levels of mRNA on a genome-wide scale.  </p>
Abstract
We describe an analysis, applicable to any spotted microarray dataset produced using genomic
DNA as a reference, that quantifies prokaryotic levels of mRNA on a genome-wide scale. Applying
this to Mycobacterium tuberculosis, we validate the technique, show a correlation between level of
expression and biological importance, define the complement of invariant genes and analyze
absolute levels of expression by functional class to develop ways of understanding an organism's
biology without comparison to another growth condition.
Background
The biological landscape has been transformed by the
sequencing of genomes, and more recently by global gene
expression analyses using microarrays [1,2]. Microarrays
contain DNA probes representing all coding sequences in a
genome, which are either synthesized in situ or are spotted
onto a modified glass surface [3]. Comparison of mRNA from
two conditions by competitive hybridization to these probes is
used to identify differentially expressed genes [1]. In the case
of spotted microarrays, these are performed either with
labeled cDNA prepared from separate mRNA preparations
co-hybridized to the same array, or as is increasingly the case,
by employing genomic DNA (gDNA) as a standard reference
[4]. In the latter case, each cDNA preparation is hybridized
separately alongside a gDNA reference and differential
expression is determined using a ratio of ratios. The use of
gDNA corrects for most spatial and spot-dependent biases
inherent with microarrays, and also allows direct comparison
between multiple datasets [4]. These are sometimes called
type 2 experiments, with RNA:RNA hybridizations being type
1 [5]. Traditionally, microarray experiments focus almost
exclusively on changes in gene expression, and in the case of
a type 1 experiment this is the only possible interpretation.
Focusing on changes in expression has helped to direct us
toward genes that warrant further investigation; however, it
Published: 13 December 2007
Genome Biology 2007, 8:R265 (doi:10.1186/gb-2007-8-12-r265)
Received: 15 August 2007
Revised: 1 November 2007
Accepted: 13 December 2007
The electronic version of this article is the complete one and can be 
found online at http://genomebiology.com/2007/8/12/R265Genome Biology 2007, 8:R265
http://genomebiology.com/2007/8/12/R265 Genome Biology 2007,     Volume 8, Issue 12, Article R265       Sidders et al. R265.2
has been shown in recent meta-analyses that up-regulated
genes may bear little correlation to other measures of biolog-
ical importance [6-8]. One reason for this lack of correlation
is that, in a traditional microarray experiment, absolute levels
of mRNA are not considered; thus, no difference is reported
between a gene where expression increases from 20 to 100
copies and one where it increases from 20,000 to 100,000
copies, yet the biological inference may be very different. Fur-
thermore, all genes whose level of expression does not alter
significantly between conditions are completely ignored and
we do not know if they are constitutively off or on (and if so,
at what level). Differential expression analysis thus provides
us with an incomplete view of the transcriptome, whereas the
determination of global mRNA levels could, in part, address
this.
Global mRNA abundance analysis is particularly applicable in
prokaryotes, where, in contrast to the situation in eukaryotes,
transcription and translation are tightly coupled [9,10]. In
prokaryotes, therefore, absolute mRNA levels might be
expected to accurately predict levels of protein. In support of
this, it has been shown in both Escherichia coli and Mycobac-
terium smegmatis that the most readily detectable (and
hence most abundant) proteins correspond to genes with
h i g h  t r a n s c r i p t  l e v e l s  [ 1 1 , 1 2 ] .  A l s o ,  i n  e x p e r i m e n t s  w h e r e
transcriptomic and proteomic data were compared, for the
majority of genes, changes at the transcriptional level were
mirrored at the protein level [13,14]. Furthermore, a compre-
hensive study of mRNA and protein levels in a sulfur-reduc-
ing bacterium identified a modest global correlation between
the two but found that the majority of the variation could be
attributed to errors in the protein analytical techniques, indi-
cating the actual correlation could be much stronger [15].
Surprisingly, the study of absolute levels of mRNA on a global
scale has largely been ignored, despite attempts that have
been made to extract meaningful quantitative information
from microarrays. These include spiking various control sam-
ples of known concentration into the hybridization mixture
[16,17], and using synthesized oligos complementary to every
spot on an array at a known concentration as a normaliser
[18]. Another recent report described the use of the Affyme-
trix gene chip platform to provide a quantitative view of gene
expression levels in prokaryotes [19]. These approaches are
often impractical or, especially with commercial systems,
prohibitively expensive. Type 2 experiments performed on
spotted arrays on the other hand, which use gDNA as a refer-
ence, are already routinely being performed, require a mini-
mal cost increase and could allow us to study the relative
abundance of each mRNA species [17] in parallel with tradi-
tional fold expression analyses.
Here we have focused on the determination of genome-wide
mRNA levels of M. tuberculosis using type 2 microarrays for
which we had a large number of datasets available. We have
developed and validated the approach, characterized the
genes whose level of expression is the highest in the transcrip-
tome in vitro and those whose level of expression remains
consistently high across a variety of environmental condi-
tions. In addition, we have coupled genome-wide levels of
mRNA abundance with a functional classification system in
order to develop ways of understanding an organism's biology
without comparison to another growth condition.
Results and discussion
Calculating relative mRNA abundance
Genome-wide transcriptional analyses have until now
focused almost exclusively on differential expression. Meth-
ods that have been developed to quantify absolute mRNA
abundances have largely been ignored or proved impractical.
However, the use of gDNA as a reference channel in tradi-
tional microarray experiments is increasingly common [4],
and as this is equivalent to an equimolar concentration of all
transcripts we have investigated using this as a normaliser
that would allow us to generate a measure of genome wide
mRNA abundances.
Initially we calculated relative mRNA abundances for M.
tuberculosis growing aerobically in chemostat cultures as we
had access to the RNA used for hybridization to the arrays,
allowing us to experimentally validate our analysis. RNA and
microarray procedures were carried out as described in the
Materials and methods and [20]. To obtain a measure of
mRNA abundance, we first removed the local background flu-
orescence from each probe spot on the microarray. The fluo-
rescence intensity from the RNA channel was then
normalized to that of the gDNA channel, after which the tech-
nical and biological replicates were averaged.
We then found it necessary to correct for a probe length effect
present in the data. In a traditional microarray (type 1) exper-
iment, comparisons are made between two cDNA populations
hybridized to one spot. Although in most cases it is necessary
to control for factors such as the spatial dependent effects of
hybridization, and normalizations such as loess are routinely
implemented for this purpose [21], it is not necessary to con-
trol for individual spot variations as these would be negated
when calculating fold expression ratios. In our case, where we
are attempting to draw comparison between signals gener-
ated from different spots on the array, we are faced with addi-
tional factors that could introduce bias to our results - those
that differ between spots on the array, for example, the probe
GC content and length. Using the signal reported from a
gDNA hybridization, we investigated these factors. We found
that the length of the probes, which ranged in length from 60
to 1,000 bp, affected the hybridization whereby longer probes
report higher signal intensities (Figure 1a). We suspect this
may be because larger probes are able to bind more DNA and
bind it more strongly than shorter probes. We corrected for
this effect using a model of linear regression (Figure 1b; and
see Materials and methods).http://genomebiology.com/2007/8/12/R265 Genome Biology 2007,     Volume 8, Issue 12, Article R265       Sidders et al. R265.3
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Finally, as the sum of all fluorescence intensities is equal to
the sum of all labeled mRNA, the measures of mRNA abun-
dance were converted from unintuitive ratios to a propor-
tional value; parts per million (ppm). Table 1 shows the
mRNA abundance values for the 50 most highly expressed
genes of M. tuberculosis. Figure 1c shows the mRNA levels, in
ppm, for each gene in the M. tuberculosis chromosome and
their log distribution is shown in Figure 1d. It is clear that the
mRNA abundances, even once log transformed, are not nor-
mally distributed, which reflects the observations of others
[22].
Validation of mRNA abundance data
In order to validate our estimates of abundance, we per-
formed quantitative reverse transcriptase PCR (RTq-PCR) on
a large selection of genes that we had predicted to span the
Probe length normalization and quantified gene expression levels in M. tuberculosis Figure 1
Probe length normalization and quantified gene expression levels in M. tuberculosis. (a) We found that longer probes correlated with increased fluorescent 
intensities, which then biased the ppm values we obtained. (b) We are able to remove this bias using a model of linear regression. The three distinct 
groupings visible in the figure are an artifact of the probe lengths targeted during their synthesis by PCR. (c) The level of expression for each gene in the 
genome, as determined by our analysis from chemostat grown wild-type M. tuberculosis H37Rv, is shown ordered as they appear in the chromosome. (d) 
The log frequency distribution of mRNA abundances from (c). A clear skew to the right, containing a subset of very highly expressed genes, is typical of the 
distributions we have found.
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Table 1
The 50 most highly expressed genes in vitro
Rv Name ppm Function [40]
1 Rv0009 ppiA 13,634 Protein translation and modification
2 Rv2527 Rv2527 10,020 Conserved hypotheticals
3 Rv3418c groES 8,651 Chaperones-heat shock*
4 Rv3615c Rv3615c 8,531 Conserved hypotheticals*
5 Rv0440 groEL2 8,300 Chaperones-heat shock*
6 Rv3258c Rv3258c 5,430 Unknown*
7 Rv3616c Rv3616c 5,370 Conserved hypotheticals*
8 Rv3477 PE31 5,138 PE subfamily
9 Rv2244 acpM 4,935 Synthesis of fatty and mycolic acids*
10 Rv0060 Rv0060 4,616 Unknown*
11 Rv3874 Rv3874 4,490 Conserved hypotheticals
12 Rv3875 esat6 4,115 SP, L, P and A†
13 Rv3648c cspA 4,101 Adaptations and atypical conditions*
14 Rv3053c nrdH 3,934 2'-Deoxyribonucleotide metabolism
15 Rv3614c Rv3614c 3,748 Conserved hypotheticals*
16 Rv1078 pra 3,582 Conserved hypotheticals
17 Rv2780 ald 3,577 Amino acids and amines
18 Rv1388 mIHF 3,499 Nucleoproteins*
19 Rv0003 recF 3,371 DNA R, R R and R‡
20 Rv3786c Rv3786c 3,164 Unknown
21 Rv1641 infC 2,993 Protein translation and modification*
22 Rv3269 Rv3269 2,778 Chaperones-heat shock
23 Rv1398c Rv1398c 2,777 Conserved hypotheticals
24 Rv3407 Rv3407 2,732 Conserved hypotheticals
25 Rv2245 kasA 2,693 Synthesis of fatty and mycolic acids*
26 Rv0685 tuf 2,688 Protein translation and modification*
27 Rv2145c wag31 2,652 SP, L, P and A*†
28 Rv1306 atpF 2,620 ATP-proton motive force*
29 Rv0005 gyrB 2,466 DNA R, R R and R*‡
30 Rv1305 atpE 2,455 ATP-proton motive force*
31 Rv0016c pbpA 2,423 Murein sacculus and peptidoglycan
32 Rv1622c cydB 2,418 Electron transport*
33 Rv3219 whiB1 2,373 Repressors-activators
34 Rv3583c Rv3583c 2,345 Repressors-activators
35 Rv1980c mpt64 2,254 SP, L, P and A†
36 Rv1072 Rv1072 2,205 Other membrane proteins
37 Rv2457c clpX 2,200 Proteins, peptides and glycopeptides*
38 Rv1958c Rv1958c 2,195 Unknown
39 Rv3763 lpqH 2,180 Lipoproteins (lppA-lpr0)
40 Rv1872c lldD2 2,149 Aerobic respiration
41 Rv3461c rpmJ 2,133 Ribosomal protein synthesis*
42 Rv1361c PPE19 2,127 PPE family
43 Rv0097 Rv0097 2,123 Conserved hypotheticals
44 Rv1971 Rv1971 2,034 Virulence
45 Rv3051c nrdE 1,984 2'-Deoxyribonucleotide metabolism*
46 Rv2346c Rv2346c 1,937 Conserved hypotheticals
47 Rv3679 Rv3679 1,931 Anions*
48 Rv1298 rpmE 1,883 Ribosomal protein synthesis*
49 Rv0108c Rv0108c 1,837 Unknown
50 Rv2193 ctaE 1,793 Aerobic respiration*
*Essential genes (TraSH) [26,27]. †Surface polysaccharides, lipopolysaccharides, proteins and antigens. ‡DNA replication, repair, recombination and 
restriction-modification.http://genomebiology.com/2007/8/12/R265 Genome Biology 2007,     Volume 8, Issue 12, Article R265       Sidders et al. R265.5
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mRNA abundance spectrum (n = 24). The RTq-PCR was car-
ried out on a sample of the same RNA used for the microarray
hybridizations. The measures of mRNA abundance as pre-
dicted from the microarray analysis show a good correlation
(Spearman's rank = 0.86, p < 0.0001) with the absolute copy
number as determined by RTq-PCR data (Figure 2).
Further validation of the method was provided by its high
reproducibility when applied to data sets from independent
laboratories using the same microarray designs. Correlations
were determined for a variety of mRNA abundance data from
both M. tuberculosis and the highly similar Mycobacterium
bovis [23]. Chemostat-grown M. tuberculosis showed a corre-
lation of 0.8 (p < 0.0001) with the homologous genes in che-
mostat-grown M. bovis. The same was true of batch-cultured
M. tuberculosis and M. bovis grown in different institutions.
However, there was a lower correlation of 0.5 (p < 0.0001)
between chemostat and batch cultured M. tuberculosis from
different laboratories, suggesting that the method of culture
significantly affects the transcriptome.
mRNA abundance, protein abundance and gene 
importance
To explore the possibility that global measures of mRNA
abundance are an important indicator of prokaryotic biology,
we compared our mRNA abundance data with proteome and
gene essentiality data. Demonstrating a correlation between
mRNA and protein levels is difficult without the availability of
genome-wide measures of protein abundance. We looked
instead at the list of M. tuberculosis proteins identified to
date from two-dimensional PAGE analysis and stored in an
online database [24]. As the mRNA abundances are not nor-
mally distributed, we determined the frequency of identified
proteins in each quartile of the abundance distribution. Of the
283 unique proteins identified in M. tuberculosis cell lysates
and supernatants, the majority (187 proteins, 66%) are
expressed in the most abundant quartile (Figure 3a). Others
have suggested that proteomic experiments have an intrinsic
bias toward abundant proteins [12,25] and this would sup-
port our hypothesis that the most abundant transcripts pro-
duce high levels of protein in bacteria. In addition, our
analysis makes no allowance for differential rates of transla-
tion initiation or mRNA/protein degradation, so this finding
reflects how tightly coupled the systems of transcription and
translation are in prokaryotes [9,10].
As there is little correlation between reports of biological
importance and gene induction [6-8] we instead looked at the
correlation with mRNA abundance. We compared the
genome-wide values of mRNA abundance with the genes
identified as being essential in M. tuberculosis by genome-
wide transposon mutant library (TraSH) screens [7,26,27].
For our RTq-PCR validated data from M. tuberculosis grow-
ing under aerobic chemostat conditions we found that there is
a significant relationship between expression level and essen-
tiality on a global scale (Chi-squared test for trend in propor-
tions = 161.2, df = 1, p value < 0.0001; Figure 3b). This is in
contrast to the lack of correlation with fold-induction upon
infection [6,7] and illustrates the potential importance of
determining mRNA abundances on a global scale. The corre-
lation may reflect our previous finding that the more highly
expressed a gene, the more protein is produced. Although
there are obvious examples where proteins with essential
functions, such as the cell division apparatus or many
Microarray analysis validation Figure 2
Microarray analysis validation. There is a strong correlation (0.86, 
Spearman's rank, p < 0.0001) between mRNA levels as predicted by our 
microarray analysis and mRNA copy number as determined by RTq-PCR.
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highly expressed genes (Chi-squared test for trend in proportions = 251.9, 
df = 1, p value < 0.0001). (b) Similarly, there is a significant relationship 
between expression level and essentiality as determined by TraSH 
[7,26,27] (Chi-squared test for trend in proportions = 161.2, df = 1, p 
value < 0.0001).
Q1 Q2 Q3 Q4
N
u
m
b
e
r
 
o
f
 
I
d
e
n
t
i
f
i
e
d
 
P
r
o
t
e
i
n
s
0
50
100
150
200
(a)
Q1 Q2 Q3 Q4
N
u
m
b
e
r
 
o
f
 
e
s
s
e
n
t
i
a
l
 
g
e
n
e
s
 
(
T
r
a
S
H
)
0
50
100
150
200
250
300
350
(b)
Quartiles (n=964); least (Q1)  most (Q4) abundantGenome Biology 2007, 8:R265
http://genomebiology.com/2007/8/12/R265 Genome Biology 2007,     Volume 8, Issue 12, Article R265       Sidders et al. R265.6
enzymes, need not be (or indeed cannot be) highly expressed
[28], prokaryotic cells would waste considerable energy syn-
thesizing large amounts of proteins that do not have essential
functions.
The most highly expressed genes of M. tuberculosis
The genome-wide distribution of mRNA levels from M.
tuberculosis cultured aerobically in the chemostat is typical of
the distributions we have found (Figure 1d). Despite being log
transformed, the distribution shows a skew to the right, sug-
gesting the presence of a highly expressed subpopulation. As
we and others have shown, the coupling of transcription and
translation in prokaryotes means that there is an enormous
material investment in transcribing a gene at a high level. We
therefore analyzed the most abundant mRNAs in some detail,
focusing on the 95th percentile of genes, that is, the 5% most
abundant transcripts, n = 198 (Additional data file 1). Of these
198 genes, 89 (45%) were reported as essential in the TraSH
experiments, which is significantly higher than the 23% of all
genes that are essential (Χ2 p < 0.001). Of the 89 essential
genes, 76 (38%) were essential in vitro, 11 (5%) in vivo and 2
(1%) are essential for survival in macrophages [7,26,27].
The most highly expressed gene in vitro was ppiA (Rv0009),
a probable peptidyl-prolyl cis-trans isomerase involved in
protein folding, which makes up 13,634 ppm (which is equiv-
alent to 1.3%) of the total mRNA population. As would be
expected, many of the very abundant transcripts belong to the
protein synthesis machinery, including thirty ribosomal pro-
teins, six translation initiation factors and various compo-
nents of RNA polymerase.
Several of the very abundant genes have previously been
characterized as highly expressed and extensively docu-
mented as important virulence determinants of M. tuberculo-
sis. In particular, some members of the esx gene family have
been shown to be critical in infection, although dispensable in
vitro. The paradigms for this family are esat6 (Rv3875) and
cfp10  (Rv3874), whose products form a secreted complex
that interacts with host cells [29]. Furthermore, they are
potent immunogens with potential roles as both subunit vac-
cines and diagnostic agents [30,31]. The esx  family in M.
tuberculosis contains 23 esat6-like genes, with 11 esat/cfp
gene pairs [32]. Including esat6 and cfp10, we identified 12
members (52%) of this family as being amongst the most
highly transcribed of all genes. One such pair of genes, esxV
(Rv3619c) and esxW (Rv3620c), are adjacent to, but not tran-
scribed with, the SNM (secretion in mycobacteria) operon
containing Rv3616c (espA),  Rv3615c  (snm9) and Rv3614c
(snm10), which we also find are very highly expressed. Two
groups have recently shown that the SNM system functions to
export both ESAT-6 and CFP-10 [33,34].
We have also observed five highly expressed transcripts
belonging to the PE/PPE family; a set of approximately 100
genes encoding proteins with proline and glutamate rich
motifs that are found exclusively within the mycobacteria
[35]. Some members of this family are located adjacent to esx
genes, suggesting a functional association, and it is now
known that a PE/PPE pair form a stable dimer, reminiscent of
ESAT-6/CFP-10 themselves [36]. Of the five PE/PPE genes in
our very abundant transcript list, two are located adjacent to
highly expressed esx family gene pairs: PPE18 (Rv1196) with
esxKL  (Rv1197/Rv1198), and PE19  (Rv1791) with esxMN
(Rv1792/Rv1793). The significance of linked high expression
levels between esx and PE/PPE genes suggests a co-function-
ality critical to M. tuberculosis biology.
Genes of unknown function
Thirty-three percent of the coding sequences in M. tuberculo-
sis were classified as having no known function in a re-anno-
tation of the genome [37]. A similar proportion (60 of 198,
30%) of the transcripts we have classified as very abundant in
M. tuberculosis are annotated as unknown, hypothetical or
conserved hypothetical proteins. The organism consumes
considerable energy in their expression so it is likely they have
important functions, and indeed 12 of these unknown genes
are essential. Using both BLASTP and functional predictions
generated with the hidden Markov model profile tool
SHARKhunt [38], we were unable to ascribe any further func-
tions to these genes with the exception of Rv0097, which has
close homology to a taurine dioxygenase of the Streptomyces,
Ralstonia  and  Chromobacterium  species. It has been
reported [39] that the Rv0097  homologue in M. bovis is
located in an operon essential for the synthesis of the viru-
lence associated lipids phthiocerol dimycocerosate esters
(PDIMs) and could function as an α-ketoglutarate-dependent
dioxygenase, the super family to which taurine dioxygenases
belong.
The invariome
Much effort goes into looking for genes whose expression is
modulated in different environments. Although it is likely
that most, if not all, genes are regulated to some extent, using
the analysis described here it is possible to search for genes
whose expression does not change significantly, which we
term 'invariant'. These may represent genes whose functions
are so important that they cannot be switched off. To identify
these invariant genes, we compared the mRNA abundance in
a total of six data sets including various growth conditions,
such as chemostat, batch culture, low oxygen and growth in
macrophages. We focused on genes that were within the 85th
percentile and found that 133 genes were consistently highly
expressed across all of the conditions tested (Table 2).
Notable members of this abundant invariome include several
esx-related genes (esat6, cfp10 and the SNM secretion sys-
tem), the paired PE31 and PPE60, groEL2 (the 65 kDa anti-
gen) and the ATP synthase operon (atpA-atpH). Compared to
a global 23% of genes that are essential, 53% (70 of 133, Χ2 p
< 0.001) of the genes in the abundant invariome are essential
for either in vitro growth or survival in mice or macrophageshttp://genomebiology.com/2007/8/12/R265 Genome Biology 2007,     Volume 8, Issue 12, Article R265       Sidders et al. R265.7
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Table 2
The 133 genes of the 'abundant invariome'
Rv Name Avg ppm Stdev Essential
1 Rv3874 lhp 5,414 3,950 -
2 Rv3418c groES 5,189 2,593 In vitro
3 Rv0440 groEL2 4,438 2,385 In vitro
4 Rv3615c Rv3615c 3,887 2,539 In vivo
5 Rv0009 ppiA 3,460 4,587 -
6 Rv3616c Rv3616c 2,619 1,457 In vivo
7 Rv3477 PE31 2,537 1,553 -
8 Rv2244 acpM 2,475 1,304 In vitro
9 Rv3875 esat6 2,472 1,229 -
10 Rv1398c Rv1398c 2,449 1,311 -
11 Rv3648c cspA 2,372 1,149 In vitro
12 Rv2245 kasA 2,236 481 In vitro
13 Rv3614c Rv3614c 2,232 847 In vivo
14 Rv1307 atpH 2,151 1,195 In vitro
15 Rv0667 rpoB 2,105 563 In vitro
16 Rv1388 mihF 2,103 1,013 In vitro
17 Rv0685 tuf 2,100 792 In vitro
18 Rv3583c Rv3583c 2,096 2,027 -
19 Rv3053c nrdH 1,930 1,339 -
20 Rv1133c metE 1,915 323 In vitro
21 Rv1072 Rv1072 1,897 560 -
22 Rv1872c lldD2 1,817 574 -
23 Rv3461c rpmJ 1,814 795 In vitro
24 Rv2457c clpX 1,790 343 In vitro
25 Rv0700 rpsJ 1,693 1,148 In vitro
26 Rv1078 pra 1,643 971 -
27 Rv1298 rpmE 1,529 543 In vitro
28 Rv2840c Rv2840c 1,495 566 -
29 Rv1630 rpsA 1,491 439 In vitro
30 Rv0046c ino1 1,488 620 -
31 Rv1886c fbpB 1,464 1,168 -
32 Rv2196 qcrB 1,455 472 In vitro
33 Rv3443c rplM 1,447 300 In vitro
34 Rv0701 rplC 1,421 880 In vitro
35 Rv0682 rpsL 1,419 576 In vitro
36 Rv3219 whiB1 1,384 795 -
37 Rv0702 rplD 1,364 619 In vitro
38 Rv0289 Rv0289 1,351 845 In vitro
39 Rv2200c ctaC 1,332 1,406 In vitro
40 Rv1980c mpt64 1,316 629 -
41 Rv1306 atpF 1,246 695 In vitro
42 Rv2193 ctaE 1,217 334 In vitro
43 Rv1310 atpD 1,184 412 In vitro
44 Rv1174c Rv1174c 1,165 424 -
45 Rv1308 atpA 1,148 349 In vitro
46 Rv3051c nrdE 1,123 578 In vitro
47 Rv1305 atpE 1,086 696 In vitro
48 Rv0683 rpsG 1,080 541 In vitroGenome Biology 2007, 8:R265
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49 Rv1297 rho 1,074 281 In vitro
50 Rv2461c clpP1 1,028 346 -
51 Rv0655 mkl 1,024 385 In vivo
52 Rv3052c nrdI 1,018 551 -
53 Rv3801c fadD32 1,015 209 In vitro
54 Rv0005 gyrB 1,011 684 In vitro
55 Rv0704 rplB 1,011 528 In vitro
56 Rv3412 Rv3412 1,002 141 -
57 Rv0250c Rv0250c 995 439 -
58 Rv2460c clpP2 991 393 In vitro
59 Rv2204c Rv2204c 963 277 -
60 Rv3478 PPE60 957 360 -
61 Rv0703 rplW 956 556 In vitro
62 Rv2094c tatA 949 241 -
63 Rv1303 Rv1303 939 637 In vitro
64 Rv3456c rplQ 937 297 -
65 Rv0719 rplF 925 406 In vitro
66 Rv0684 fusA1 923 367 In vitro
67 Rv2347c Rv2347c 920 447 -
68 Rv0715 rplX 906 342 In vitro
69 Rv1197 Rv1197 906 440 -
70 Rv1479 moxR1 898 162 In vitro
71 Rv0718 rpsH 886 243 In vitro
72 Rv3460c rpsM 882 373 -
73 Rv2194 qcrC 870 194 In vitro
74 Rv2195 qcrA 868 189 In vitro
75 Rv0860 fadB 863 420 -
76 Rv1309 atpG 861 401 In vitro
77 Rv0243 fadA2 859 231 -
78 Rv3248c sahH 850 243 In vitro
79 Rv0020c TB39.8 850 224 -
80 Rv3584 lpqE 845 246 -
81 Rv1793 Rv1793 836 309 -
82 Rv3620c Rv3620c 827 375 -
83 Rv1410c Rv1410c 815 188 In vivo
84 Rv3459c rpsK 809 206 In vitro
85 Rv0483 lprQ 805 341 -
86 Rv3043c ctaD 803 221 In vitro
87 Rv3029c fixA 801 232 In vitro
88 Rv2868c gcpE 799 384 -
89 Rv1304 atpB 796 203 In vivo
90 Rv1642 rpmI 784 388 -
91 Rv1794 Rv1794 781 254 -
92 Rv0288 cfp7 781 286 -
93 Rv3810 pirG 778 131 In vivo
94 Rv1543 Rv1543 770 222 -
95 Rv3680 Rv3680 765 294 -
96 Rv3457c rpoA 760 293 In vitro
97 Rv3045 adhC 756 272 -
98 Rv1792 Rv1792 753 326 -
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[7,26,27]. Twenty-two of our abundant invariome genes have
no known function, two of which (Rv0289 and Rv1303) are
essential. These and other members of the abundant invari-
ome are primary candidates for future functional studies that
may elucidate key mycobacterial biology.
As well as an obvious hypothesis generation role, such invar-
iant gene analyses might have uses, for example, in identify-
ing strong antigens, constitutive promoters and stable
housekeeping genes expressed in all environments. Further-
more, as significant proportions of the abundant invariome
are essential, this analysis also has the potential to identify
drug targets or candidate virulence factors in prokaryotes
even if no other biological information is known.
Highly transcribed functional categories
The advent of systems biology is encouraging the develop-
ment of techniques that reveal more holistic information
about biological systems. We have therefore combined our
measures of M. tuberculosis mRNA abundance with a non-
overlapping classification system based on known or
predicted functions [40,41]. Not only does this accord with
the aims of systems biology, it would also remove the need to
routinely compare expression profiles to that of artificial lab-
99 Rv2969c Rv2969c 738 141 In vitro
100 Rv1177 fdxC 736 303 In vitro
101 Rv3867 Rv3867 735 200 -
102 Rv1038c Rv1038c 724 391 -
103 Rv2890c rpsB 715 120 In vitro
104 Rv3224 Rv3224 709 303 -
105 Rv3458c rpsD 707 208 In vitro
106 Rv2785c rpsO 690 316 -
107 Rv2986c hupB 687 255 In vitro
108 Rv0174 mce1F 683 211 -
109 Rv3211 rhlE 676 251 -
110 Rv1436 gap 673 234 In vitro
111 Rv0351 grpE 672 282 In vitro
112 Rv2764c thyA 667 239 -
113 Rv1311 atpC 660 160 In vitro
114 Rv0432 sodC 657 177 -
115 Rv1791 PE19 655 232 -
116 Rv0932c pstS2 652 249 -
117 Rv2971 Rv2971 645 188 In vitro
118 Rv1300 hemK 644 220 In vitro
119 Rv2703 sigA 643 114 In vitro
120 Rv2203 Rv2203 633 196 -
121 Rv0423c thiC 614 149 In vitro
122 Rv2587c secD 602 267 -
123 Rv1887 Rv1887 601 148 -
124 Rv0313 Rv0313 588 136 -
125 Rv0502 Rv0502 559 147 -
126 Rv3841 bfrB 542 107 -
127 Rv2115c Rv2115c 529 106 -
128 Rv3587c Rv3587c 526 68 -
129 Rv2110c prcB 516 151 In vitro
130 Rv1987 Rv1987 495 136 -
131 Rv2454c Rv2454c 489 55 -
132 Rv0125 pepA 483 80 -
133 Rv1324 Rv1324 474 152 -
Using our measure of absolute mRNA levels, we have been able to identify the genes whose level of expression remains consistently high across a 
variety of growth conditions. These genes remain amongst the top 15% most highly expressed genes across all of the conditions tested. We have 
termed the genes whose level of expression does not vary greatly as invariant, and, therefore, the subset of genes included in this table is dubbed the 
'abundant invariome'.
Table 2 (Continued)
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oratory conditions and could, therefore, be more biologically
meaningful.
Using this analysis to study the transcriptome of M. tubercu-
losis in a disease relevant [42] low oxygen state (chemostat
grown at a dissolved oxygen tension (DOT) of 0.2% [20])
reveals that, at the broadest scope of the classification system,
29% of the mRNA in the transcriptome codes for proteins
involved in small molecule metabolism, 19% for macromole-
cule metabolism, 7% for 'other' functions (virulence, and so
on) and 7% for cellular processes. In addition, 38% of the in
vitro  low oxygen transcriptome codes for proteins of
unknown function, illustrating how little of mycobacterial
biology has been characterized to date.
To determine which functional classes, at all levels of the clas-
sification system, were significantly over- or under-repre-
sented in the transcriptome, we chose, for comparison, three
different robust and nonparametric approaches: robust lin-
ear modeling, bootstrap-t using the Q statistic of Davison and
Hinkley [43], and a bootstrap-t using trimmed means and
winsorized variances [44]. We removed all classes with fewer
than four data points to be able to obtain variance estimates
after trimming. As an example of how this might be used, we
again focused on the low oxygen transcriptome. In this exam-
ple, many of the functional classes that we have shown to be
significantly over-represented within the transcriptome by all
three tests reflect the growth rate in the chemostat (main-
tained at a 24 hour doubling time [20]), including the protein
translation machinery, the chaperones, the RNA and DNA
synthesis mechanisms, and the ribosomal proteins (Addi-
tional data file 2). Also abundant are classes involved with
energy metabolism, including ATP synthesis and the TCA
cycle, as well as macromolecule synthesis, including the fatty
and mycolic acid anabolic pathways.
Using either of the bootstrap-t methods appears to be too
stringent to reveal classes that we would immediately recog-
nize as reflecting the adaptation to low oxygen. However, the
classes deemed significant by the robust linear modeling
method include the glyoxylate shunt enzymes, which are
essential in vivo for the anaplerosis of acetyl-CoA when grow-
ing on fatty acids [45,46], and the oxidative electron transport
system known to operate under reduced oxygen tensions in
mycobacteria [47].
Our functional analyses are only preliminary; we are limited
by the lack of a comprehensive bacterial gene ontology. How-
ever, we suggest that this is a biologically relevant approach
that could be expanded and used to identify the key cellular
and metabolic processes require d  b y  a n  o r g a n i s m  i n  a
particular growth condition. It will link well with other sys-
tems biology analyses to produce useful insights into bacterial
physiological states and, for example, could be used to deter-
mine the processes, rather than the components, required for
infection and latency in M. tuberculosis.
Conclusion
We have developed a method of microarray analysis that
quantifies levels of mRNA on a genome-wide scale. Our
method of analysis can be applied to any spotted microarray
data set produced using gDNA as a reference channel. Apply-
ing this analysis to the prokaryote M. tuberculosis, we have
identified the most highly expressed genes and note correla-
tions with gene essentiality as well as with a basic measure of
protein abundance. We have also been able to define the sub-
set of genes that are invariantly highly expressed and find that
more than half are essential for growth in vitro or survival in
vivo. In addition, we are also able to produce a functionally
organized holistic view of the transcriptome. Alongside tradi-
tional changes in expression, mRNA abundance analysis can,
therefore, greatly enhance the utility of microarray data and
has numerous additional uses that will aid genetic research
into prokaryotic organisms.
Materials and methods
Microarrays
Six microarray datasets have been used in this study (Table
3). The microarrays used for hybridization were the BμG@S
TB version 1 arrays (Array Express accession: A-BUGS-1)
[48], for data sets 1 to 3, containing 3,924 spotted PCR prod-
ucts and TB version 2 arrays (A-BUGS-23) [48], for data sets
Table 3
Microarray datasets used in this study
Description Origin Reference Data storage
1 Wild-type Mtb H37Rv aerobic chemostat CAMR, UK [20] BμG@Sbase: E-BUGS-60
2 Wild-type Mtb H37Rv low oxygen chemostat - 0.2% DOT CAMR, UK [20] BμG@Sbase: E-BUGS-60
3 Wild-type Mtb H37Rv aerobic rolling batch culture RVC, UK Unpublished BμG@Sbase: E-BUGS-60
4 Wild-type Mbovis AF2122/97 aerobic chemostat VLA, UK Unpublished BμG@Sbase: E-BUGS-60
5 Wild-type Mbovis AF2122/97 aerobic rolling batch culture VLA, UK Unpublished BμG@Sbase: E-BUGS-60
6 Wild-type Mtb H37Rv harvested from macrophages SGUL, UK Unpublished BμG@Sbase: E-BUGS-60http://genomebiology.com/2007/8/12/R265 Genome Biology 2007,     Volume 8, Issue 12, Article R265       Sidders et al. R265.11
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4 to 6, containing 4,410 spotted PCR products, including
additional open reading frames from M. bovis strain AF2122/
97. Fully annotated microarray data have been deposited in
BμG@Sbase (accession number E-BUGS-60) [49] and also
ArrayExpress (accession number E-BUGS-60).
Bacterial culture
Batch cultures of M. tuberculosis and M. bovis were grown in
100 ml Middlebrook 7H9 (Becton, Dickinson and Co. Frank-
lin Lakes, NJ, USA) supplemented with 10% Middlebrook
OADC (Becton, Dickinson and Co.) in 1 liter capacity flasks
that were continuously rolled at 37°C. Chemostat cultures,
RNA extraction and microarray hybridizations were per-
formed as detailed in Bacon et al. 2004 [20]. Briefly, 500 ml
cultures were grown to steady state conditions in 1 liter chem-
ostat fermentation vessels maintained at 37°C, with a pH of
6.9 and a generation time of 24 hours. Aerobic cultures were
kept at a DOT of 10% whilst low oxygen cultures were main-
tained at 0.2% DOT.
RNA and genomic DNA extraction
Aliquots of the bacterial cultures (10 ml) were sampled
directly into four volumes of a guanadinium thiocyanate
based stop solution. After centrifugation and resuspension in
either Trizol (Invitrogen, Carlsbad, California, USA) or
additional stop solution, cells were lysed using a Ribolyser
(Hybaid, Teddington, England) or Precellys 24 (Bertin Tech-
nologies, Montigny-le-Bretonneux, France) and RNA was
extracted using a chloroform precipitation followed by purifi-
cation with the RNeasy Mini Kit (Qiagen, Hilden, Germany).
RNA was then treated with deoxyribonuclease (DNase 1
amplification grade, Life Technologies Inc/Invitrogen,
Carlsbad, California, USA). Genomic DNA was isolated from
pellets of stationary phase mycobacterial cultures following
previously described procedures [50].
RNA/DNA labeling and hybridization
For the majority of the datasets RNA was extracted from four
independent biological replicates and each was labeled in
triplicate using 8 μg total RNA as a template for reverse tran-
scriptase (Superscript II RNAse H, Life Technologies Inc.) in
the presence of random primers (Invitrogen, Carlsbad, Cali-
fornia, USA) and Cy5 labeled dCTP. Genomic DNA (1 μg) was
used as a template for DNA polymerase (Klenow, Invitrogen,
Carlsbad, California, USA) in the presence of random primers
and Cy3 labeled dCTP.
Purified Cy3/Cy5 labeled DNA were combined and added to
the array underneath a cover slip before being sealed in a
hybridization chamber and submerged in a water bath at
65°C for 16-20 hours. Scanning was performed with a dual
laser scanner (Affymetrix 428, MWG Biotech, Ebersberg,
Germany) at a gain below saturation of the most intense
spots. Both spot and local background levels were quantified
from the resulting images using ImaGene 4.0 (MWG
Biotech).
mRNA abundance calculation
The Perl computing language and the R statistical environ-
ment [51] were used to perform all data and statistical analy-
sis. The YASMA [52] microarray analysis package for R was
used to input and structure the raw data.
Initially, all control spots on the array were removed from the
dataset, including all representing ribosomal RNA. The local
background noise, as determined by the image quantification
software, was subtracted from each spot. No data values were
excluded from this study as we reasoned weak signals (after
background subtraction) were reflective of low abundance
transcripts.
For each spot i on the array the fluorescent intensity from the
cDNA (RNA) channel was normalized by simple division to
the fluorescent intensity of the gDNA channel:
Normalized intensity (Ri) = cDNAi/gDNAi
The correlation between hybridization replicates within each
dataset was confirmed to ensure there were no extreme out-
liers. Technical and biological replicates were then averaged
to provide a single normalized intensity value for each gene
on the array.
To account for the observed probe length bias (see Results
and discussion), signal intensity was normalized to probe
length using a model of linear regression of log intensity on
probe length (Figure 1a,b):
Probe normalized intensity (loge Rni) =
loge Ri - (intercept + slope × probe lengthi)
The corrected Rni values were converted back to a raw scale
and for ease of understanding are depicted as a proportional
value, expressed in ppm, based on the assumption that the
sum of all intensity values represents the sum of the tran-
script (mRNA) population within the sample:
ppm = (Rni/∑i-ith Rn) × 106
RTq-PCR
To assess if the measures of transcript abundance from the
array analysis truly reflect that of the RNA sample we carried
out RTq-PCR on 24 genes predicted to span the spectrum of
mRNA abundances as determined by the mRNA abundance
analysis. The RNA samples used were those extracted and
used for the microarray hybridizations in data set 1 [20]. Total
RNA (400 ng) was reverse transcribed using Superscript
Reverse Transcriptase III (Invitrogen) according to the man-
ufacturer's instructions. cDNA (5 ng) was subsequently used
for RTq-PCR using the DyNAmo SYBR green qPCR kit
(Finnzymes, Espoo, Finland), according to the manufac-
turer's instructions, in a DNA Engine Opticon 2 thermal
cycler (MJ Research, Waltham, MA, USA). For each reactionGenome Biology 2007, 8:R265
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a set of gDNA standards of known copy number were used to
produce a standard curve from which a copy number could
accurately be determined. The data were analyzed using Opti-
con Monitor v2.0.
Functional category analysis
The genes of M. tuberculosis were grouped based on a Riley-
like classification system obtained from the Sanger Institute
[40]. The classification system is non-overlapping and hierar-
chical, and thus has six highest level functional categories:
small-molecule metabolism, macromolecule metabolism, cell
processes, other, conserved hypothetical and unknowns, each
of which splits into more specific subcategories. In total,
3,925 genes are classified in this system.
We were looking to compare the level of expression in each
functional class with that in other classes to discover which
classes might be over- or under-represented within the tran-
scriptome. We used ANOVA based approaches to detect func-
tional classes that show significant over- or under-
representation compared to the rest. We estimated location
parameters for the log ppm values for each class and assessed
the statistical significance of the contrast of a location param-
eter for a particular class and the average of location parame-
ters for all the other classes. As seen in Figure 1d, the mRNA
abundances are not normally distributed even after log-trans-
formation, so we could not assume that the distribution of
abundances within each class would be. Moreover, the vari-
ances changed considerably between functional classes. We
therefore chose three different robust and nonparametric
approaches to estimate the location parameters and to estab-
lish significance of contrasts: robust linear modeling; a boot-
strap-t using the Q statistic of Davison and Hinkley [43]; and
a bootstrap-t using trimmed means and winsorized variances
[44]. We removed all classes with fewer than four data points
to be able to obtain variance estimates after trimming.
For the robust linear model we used the rlm function from the
R package MASS [53], with Huber's Psi function and default
settings. In the bootstrap-t with Q values as pivot we trimmed
points with their robustly estimated residues in the top 20%
and bottom 20% quantiles before performing the bootstrap
analysis to protect the estimations against outliers. For the
second bootstrap-t we used trimmed means with 20% of the
lower and 20% of the upper quantiles removed, correspond-
ing to 20% winsorized variances for the pivot. Resampling
was done within each functional class, since we take them as
fixed effects. We collected 10,000 bootstrap samples to allow
for multiple testing correction. The method of Benjamini and
Yekutieli [54] was used to calculate a false discovery rate
allowing for dependencies between functional classes.
The results from all tests are provided as supporting informa-
tion (Additional data file 2). Classes were considered signifi-
cantly different from others if the adjusted p value was less
than 0.05.
Abbreviations
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parts per million; RTq-PCR, quantitative reverse tran-
scriptase PCR.
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